August 23, 2025Open Access

Base editing of β0 thalassemia mutations as a therapeutic strategy for β-hemoglobinopathies: efficacy and genotoxicity studies

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Gene therapy demonstrates effective β-globin correction in hematopoietic stem cells, suggesting a new treatment for β-thalassemia.

Base editing significantly improves β-globin expression and corrects β-thalassemia traits without causing safety concerns.
The editing process showed excellent outcomes in stem cells with no observed increase in mutational burden.
Using adenine base editors, the research focused on precise corrections of genetic mutations causing serious disorders.
The findings support that this gene correction approach can potentially revolutionize treatment for β-hemoglobinopathies.

Miccio et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

August 23, 2025Open Access

View Full Paper

Ask AI

Bookmark

Authors

Gene therapy demonstrates effective β-globin correction in hematopoietic stem cells, suggesting a new treatment for β-thalassemia.

Base editing significantly improves β-globin expression and corrects β-thalassemia traits without causing safety concerns.
The editing process showed excellent outcomes in stem cells with no observed increase in mutational burden.
Using adenine base editors, the research focused on precise corrections of genetic mutations causing serious disorders.
The findings support that this gene correction approach can potentially revolutionize treatment for β-hemoglobinopathies.

Miccio et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark